Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Board Appointment

2 Oct 2012 07:00

RNS Number : 6575N
Oxford Catalysts Group PLC
02 October 2012
 



2nd October 2012

 

OXFORD CATALYSTS GROUP PLC

("Oxford Catalysts" or "the Group" or "the Company")

 

Board Appointment

 

Oxford Catalysts Group PLC, the leading technology innovator for synthetic fuels production, is pleased to announce that Sandy Shaw has been appointed to the Board as a Non-executive Director with immediate effect.

 

Sandy has over 30 years of experience in the oil and gas industry, including senior executive positions as group legal counsel and / or commercial director for Consort Resources, LASMO, Esso Petroleum, Marathon Oil and Mobil. She has extensive oil and gas M&A experience, has overseen numerous material private equity subscriptions and led a £200 million trade sale through to final negotiations. She's worked as a consultant to several oil and gas companies, as well as two UK law firms. Since August 2008, Sandy has been an Executive Director Corporate and Commercial, and Company Secretary of Valiant Petroleum, a company of which she was a founder and initially a non-executive director.

 

Commenting on her appointment, Sandy Shaw said:

 

"I am delighted to join the board of Oxford Catalysts at this exciting juncture as it starts commercial roll-out. The Company is leading the field in technology for distributed scale synthetic fuels production at a time when the market is ripe for exploitation. I look forward to using my industry experience to help Oxford Catalysts realise the significant opportunities ahead."

 

Commenting on the appointment, Pierre Jungels, Chairman of Oxford Catalysts, said:

 

"I am pleased that Sandy Shaw is joining our board of directors. Her legal expertise gained in the commercial energy sector will provide a strong complement to the Group.

 

"Sandy's appointment brings to the Board a greater balance of non-executive to executive and the independence and diversity recommended by the Combined Code. This is important as the Group grows and progresses in the deployment of its world leading distributed Gas-to-Liquids offering."

 

The directorships and partnerships held by Mrs Shaw (full name: Sandra Nan Demby Shaw, nee Demby) (aged 59) now and over the five years preceding the date of appointment are as follows:

 

Current Directorships / Partnerships

Executive Director Valiant Petroleum plc.

 

Directorships in the past 5 years

SDS Energy Consultants Limited.

As at the date of this announcement, Mrs Shaw has no interests in the capital of the Company.

 

There are no other matters to be announced as required under paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

 

For further information, please contact:

 

Oxford Catalysts

Susan Robertson, CFO

 

 

+44 (0)1235 841 700

 

Cenkos Securities (Nomad and Broker)

Ken Fleming / Neil McDonald

+44 (0)20 7397 8900

+44 (0)131 220 9772

 

FTI Consulting

Billy Clegg / Alex Beagley

+44 (0)20 7831 3113

 

Notes to Editors

 

Oxford Catalysts enables modular Gas-to-Liquids ("GTL") plants to convert unconventional, remote and problem gas into valuable liquid fuels. Systems based on the Group's technology (marketed under the brand name Velocys) are significantly smaller than those using conventional technology, enabling modular plants that can be deployed cost effectively in remote locations and on smaller fields than is possible with competing systems. Together with world-class partners, Oxford Catalysts provides complete modular GTL solutions that address an untapped market of up to 25 million barrels of fuel a day.

 

Oxford Catalysts Group PLC is listed on the AIM market of the London Stock Exchange (LSE: OCG). The Group has some 85 employees with facilities near Oxford, UK and Columbus, Ohio, USA.

 

www.oxfordcatalysts.com

www.velocys.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMMGGVMKGZZM
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.